Brian Kirmse

1.5k total citations
35 papers, 774 citations indexed

About

Brian Kirmse is a scholar working on Clinical Biochemistry, Genetics and Rheumatology. According to data from OpenAlex, Brian Kirmse has authored 35 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 9 papers in Genetics and 8 papers in Rheumatology. Recurrent topics in Brian Kirmse's work include Metabolism and Genetic Disorders (13 papers), Folate and B Vitamins Research (7 papers) and HIV-related health complications and treatments (5 papers). Brian Kirmse is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Folate and B Vitamins Research (7 papers) and HIV-related health complications and treatments (5 papers). Brian Kirmse collaborates with scholars based in United States, Australia and United Kingdom. Brian Kirmse's co-authors include Marshall Summar, Johannes Häberle, Stefan Koelker, Cynthia Le Mons, Debra Freedenberg, Hye‐Seung Lee, Melissa Wasserstein, George A. Díaz, Charlotte V. Hobbs and William Borkowsky and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and The Journal of Infectious Diseases.

In The Last Decade

Brian Kirmse

35 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Kirmse United States 13 317 259 151 147 113 35 774
Jeffrey T. Talbot United States 10 67 0.2× 351 1.4× 145 1.0× 51 0.3× 96 0.8× 13 819
Rodney Russ United States 16 113 0.4× 321 1.2× 36 0.2× 91 0.6× 373 3.3× 25 956
María José García Spain 15 228 0.7× 196 0.8× 66 0.4× 54 0.4× 13 0.1× 44 766
Ikuo Nagata Japan 12 152 0.5× 83 0.3× 52 0.3× 140 1.0× 41 0.4× 29 561
Tomika Ludaway United States 12 89 0.3× 241 0.9× 17 0.1× 69 0.5× 162 1.4× 15 543
S. Li Volti Italy 14 42 0.1× 306 1.2× 38 0.3× 193 1.3× 62 0.5× 53 881
Mamta Muranjan India 15 43 0.1× 168 0.6× 73 0.5× 98 0.7× 26 0.2× 80 688
Kamel Monastiri Tunisia 12 55 0.2× 115 0.4× 55 0.4× 77 0.5× 29 0.3× 63 506
Ward Hagar United States 13 26 0.1× 139 0.5× 34 0.2× 162 1.1× 76 0.7× 24 1.1k
Mads Rauning Buhl Denmark 19 49 0.2× 110 0.4× 56 0.4× 21 0.1× 139 1.2× 48 945

Countries citing papers authored by Brian Kirmse

Since Specialization
Citations

This map shows the geographic impact of Brian Kirmse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Kirmse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Kirmse more than expected).

Fields of papers citing papers by Brian Kirmse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Kirmse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Kirmse. The network helps show where Brian Kirmse may publish in the future.

Co-authorship network of co-authors of Brian Kirmse

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Kirmse. A scholar is included among the top collaborators of Brian Kirmse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Kirmse. Brian Kirmse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karunanidhi, Anuradha, et al.. (2024). A multiomics approach reveals evidence for phenylbutyrate as a potential treatment for combined D,L-2- hydroxyglutaric aciduria. Molecular Genetics and Metabolism. 142(3). 108495–108495. 3 indexed citations
2.
Bowling, Kevin M., Michelle L. Thompson, Melissa Kelly, et al.. (2022). Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing. Genome Medicine. 14(1). 131–131. 10 indexed citations
3.
Kirmse, Brian, et al.. (2022). LPIN1 rhabdomyolysis: A single site cohort description and treatment recommendations. Molecular Genetics and Metabolism Reports. 30. 100844–100844. 3 indexed citations
4.
Jao, Jennifer, Lauren C. Balmert, Shan Sun, et al.. (2021). Distinct cord blood C-peptide, adipokine, and lipidomic signatures by in utero HIV exposure. Pediatric Research. 92(1). 233–241. 4 indexed citations
5.
Hendon, Laura G., et al.. (2021). Asynchronous telemedicine for clinical genetics consultations in the NICU: a single center’s solution. Journal of Perinatology. 42(2). 262–268. 3 indexed citations
6.
Hobbs, Charlotte V., et al.. (2020). COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes. Frontiers in Pediatrics. 8. 593455–593455. 13 indexed citations
7.
Ahrens‐Nicklas, Rebecca C., Lars Schlotawa, Andrea Ballabio, et al.. (2018). Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement. Molecular Genetics and Metabolism. 123(3). 337–346. 27 indexed citations
8.
Kirmse, Brian, et al.. (2017). Plasma fibroblast growth factor-21 levels in patients with inborn errors of metabolism. Molecular Genetics and Metabolism Reports. 13. 52–54. 2 indexed citations
9.
Jao, Jennifer, Kathleen M. Powis, Brian Kirmse, et al.. (2017). Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon. AIDS. 31(18). 2475–2481. 29 indexed citations
10.
Mew, Nicholas Ah, et al.. (2015). Deconstructing Black Swans. Advances in Neonatal Care. 15(4). 241–247. 2 indexed citations
11.
McGovern, Margaret M., Melissa Wasserstein, Brian Kirmse, et al.. (2015). Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann–Pick disease type B (acid sphingomyelinase deficiency). Genetics in Medicine. 18(1). 34–40. 46 indexed citations
12.
13.
Kirmse, Brian, Tzy‐Jyun Yao, Sean Hofherr, et al.. (2015). Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States. AIDS Research and Human Retroviruses. 32(4). 339–348. 13 indexed citations
14.
Kruszka, Paul, Brian Kirmse, Dina J. Zand, et al.. (2014). Concurrent non-ketotic hyperglycinemia and propionic acidemia in an eight year old boy. Molecular Genetics and Metabolism Reports. 1. 237–240. 5 indexed citations
15.
Castro, Mauricio De, Dina J. Zand, Uta Lichter‐Konecki, & Brian Kirmse. (2014). Severe Neonatal Holocarboxylase Synthetase Deficiency in West African Siblings. JIMD Reports. 20. 1–4. 6 indexed citations
16.
Kirmse, Brian, Charlotte V. Hobbs, Michele Caggana, et al.. (2012). Abnormal Newborn Screens and Acylcarnitines in HIV-exposed and ARV-exposed Infants. The Pediatric Infectious Disease Journal. 32(2). 146–150. 18 indexed citations
17.
18.
Weisfeld‐Adams, James D., Mark A. Morrissey, Brian Kirmse, et al.. (2009). Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Molecular Genetics and Metabolism. 99(2). 116–123. 98 indexed citations
19.
Kirmse, Brian, et al.. (2009). High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria. Molecular Genetics and Metabolism. 98(4). 344–348. 51 indexed citations
20.
Hobbs, Charlotte V., Tatiana Voza, Alida Coppi, et al.. (2008). HIV Protease Inhibitors Inhibit the Development of Preerythrocytic-StagePlasmodiumParasites. The Journal of Infectious Diseases. 199(1). 134–141. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey T. Talbot Breakdown of academic impact, for papers by Rodney Russ Breakdown of academic impact, for papers by María José García Breakdown of academic impact, for papers by Ikuo Nagata Breakdown of academic impact, for papers by Tomika Ludaway Breakdown of academic impact, for papers by S. Li Volti Breakdown of academic impact, for papers by Mamta Muranjan Breakdown of academic impact, for papers by Kamel Monastiri Breakdown of academic impact, for papers by Ward Hagar Breakdown of academic impact, for papers by Mads Rauning Buhl
Rankless by CCL
2026